NxStage Expands System One Network Coverage for ESRD Patients
Names Jeff Smith Vice President And General Manager, Home Market
LAWRENCE, Mass., June 27 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that based on recent data compiled from its patient database matched with CMS public data,
approximately 92 percent of End-Stage Renal Disease (ESRD) patients within the continental United States are now located within a 60 mile radius of a dialysis center which offers System One(TM) therapy.We are extremely pleased to have increased ESRD patient and physician access to System One via our comprehensive and growing network of dialysis centers, said Jeff Burbank, Chief Executive Officer. We are committed to further develop and invigorate these programs to deepen our penetration and extend the quality of life benefits of home dialysis to more patients.
http://www.nxstage.com/ir.cfm